Unit – 7 Insulin Initiation and Titration Type 2 Diabetes Mellitus
Learning objectives
At the end of this module participants will be able to:
- Describe the approaches in management of Type 2 diabetes
- List the rationale and indications for insulin initiation in Type 2 DM
- Choose the right insulin type and dose
- Educate the patient and family members on proper injection of insulin
- Address barriers to optimal use of insulin
- Support patients on insulin therapy
Introduction
- Diabetes is a progressive disease
- T2DM progression is characterised by decline in ß-cell function and worsening insulin resistance.
- Getting to, or maintaining, target HbA1c levels in T2DM requires intensified treatment over time.

Indications for insulin therapy in Type 2 DM
- Severe Hyperglycemia at diagnosis
– FBS > 250 mg/dl
– RBS > 300 mg/dl
– HbA1C > 9.5 %
– Ketonuria or HHS
– Severe symptoms - Patients not meeting targets on two OHA and Life Style Modification
- Intolerable side effects or unable to take medications
- Preconception Control and Pregnancy
- Plans for surgery, especially CV Surgery;
- Severe illness and Hospitalization
- Use of steroids or chemotherapy
Most patients with type 2 DM will eventually need insulin therapy
Insulin Therapy in type 2 DM
Options
- Offer NPH insulin injected at once or twice daily according to need.
- Consider starting both NPH and short-acting insulin if person’s HbA1c is 9.0% or higher, administered either:
– separately or
– as a pre-mixed (biphasic) human insulin preparation.
Insulin therapy options
- Basal insulin
– Once or twice daily, intermediate or long-acting - Premix insulin
– Once or twice daily - Rapid-acting insulin (bolus)
– Meal-time - Combination (e.g. basal-bolus)

Insulin initiation regimens
- Basal insulin
– 10 units at bed time
– Increase by 2-4 units every 3 days until fasting glucose < 130 mg/dl - Intensive insulin therapy/MDI
– 0.3-0.5 units/kg total - Divide dose 2/3 in AM + 1/3 in PM
– Increase by 2-4 units every 3 days until fasting glucose < 130 mg/dl - Pre-mixed insulin
– 10 units bid OR 0.3-0.5 units/kg divided in 2/3 in AM + 1/3 in PM
– Most difficult to titrate
MDI- multiple daily injections
Practical aspects of insulin initiation
- Start low and titrate up
- Basal insulin therapy:
– Begin at 0.1 to 0.2 U/kg of body weight = ~ 10 units at bed time and titrate to achieve target fasting, if the bed time insulin is ≥24 units, split 2/3 in AM + 1/3 in PM
– Continue metformin therapy
– Continue sulfonylureas during the day if started with bed time NPH
Practical aspects of insulin initiation…
- If patients have post prandial high blood glucose (>180 mg/dl):
– Continue Metformin and DPP-IV inhibitors
– Stop sulfonylureas
– Calculate 0.3 to 0.5 u of insulin/kg body weight
– Premixed insulin twice daily: divide as 2/3 in AM and 1/3 at supper and titrate
– Patients can also mix NPH insulin and regular insulin in 2/3 and 1/3 proportions respectively
– Have patients work closely with diabetes nurse educator or frequent follow ups in the office for adjustment.
Practical aspects of insulin…
- Insulin therapy requires a structured program employing active insulin dose titration that encompasses:
– injection technique, including rotating injection sites and avoiding repeated injections at the same point within sites
– self-monitoring
– dose titration to target levels
– dietary understanding
– management of hypoglycaemia
Barriers to insulin therapy
- There is resistance to initiate insulin despite efficacy and guideline recommendations (‘clinical inertia’)
– Patients remain on OHA therapy for years, even those with poor glycemic control - Barriers to insulin initiation are shared by patients and clinicians
- Health system factors (Access to insulin, monitoring of DM)
- Patient concerns continue even after insulin initiation
Barriers to Insulin Use: Patients
- Fear of hypoglycaemia
- Fear of reduced quality of life
- Fear of needles/pain from injections
- Reluctance to inject in public
- Perception that the disease is becoming more severe
- Patients do not feel empowered to take control of their diabetes
- Perception that insulin therapy leads to complications or death
- Misperception that insulin is only necessary in type 1 diabetes
Barriers to Insulin Use: Professionals
- Lack of
– Training
– Time
– Support & Resources - Do not treat to target
- Fear of
– Hypo
– Weight gain
– Patients’ anger
– Complex RX regimens

Determinants of insulin efficacy
- Type of insulin
- Size of subcutaneous tissue
- Injection technique
- Site of injection
- Alterations in subcutaneous blood flow
Insulin injection technique
- Injection technique is the same with insulin syringes and pen injectors
- Both the angle of needle entry and depth of penetration affect the rate of absorption
- Injections are made into the subcutaneous tissue. Most individuals are able to lightly grasp a fold of skin and inject at a 90° angle
- Thin individuals or children can use short needles or may need to pinch the skin and inject at a 45° angle to avoid intramuscular injection, especially in the thigh area
Injection sites
- Insulin may be injected into the subcutaneous tissue of the upper arm and the anterior and lateral aspects of the thigh, buttocks, and abdomen.
- Rotation of the injection site is important to prevent lipohypertrophy or lipoatrophy.
- Rotating within one area is recommended (e.g., rotating injections systematically within the abdomen) rather than rotating to a different area with each injection

Insulin storage
- Although manufacturers recommend storing insulin in the refrigerator, injecting cold insulin can sometimes make the injection more painful
- To avoid this, many providers suggest storing the bottle of insulin being used at room temperature
- Insulin kept at room temperature will last approximately 1 month
Case Study 1
A 42 year old man with diabetes for the last 03
years is taking Metformin 1000mg po bid and
Glibenclamide 5mg po bid.
His FBS is 210mg/dl today. His HbAlc is 9%. His
FBS was 300mg/dl at diagnosis but he refused
insulin initiation because of fear of
hypoglycemia and interference with his daily
routine.
He has background retinopathy and
dyslipidemia.

Case Study 1 Answer:
- This patient has poor control of both Fasting and Post
Prandial blood . - His life expectancy is long so his target HBA1C should be ~7%
- Starting with premixed insulin twice per day is
preferable(0.1-0.2 units/kg) - Educate on Insulin and Hypoglycemia
- If patient still refuses insulin add a 3rd PO agent (SGLT2
inhibitor or DPP IV inhibitor) - Moderate Intensity Statins— Simvastatin 20-40mg or
Rosuvastatin 10mg or Atorvastatin 20mg - Refer to ophthalmologist for further evaluation





